Ferroptosis-IN-6
Ferroptosis-IN-6 is a potent Ferroptosis inhibitor with an EC50 of 25.5 nM. Ferroptosis-IN-6 acts as a radical-trapping antioxidant, relying on the synergistic effect of ortho-hydroxyamine to specifically block lethal lipid ROS accumulation without affecting iron homeostasis and ROS generation pathways. Ferroptosis-IN-6 can be used for research on renal ischemia-reperfusion injury.
For research use only. We do not sell to patients.
- CAS No.: 1517780-59-4
- Formula: C15H17NO
- Molecular Weight:227.30
-
Storage:
4°C, protect from light, stored under nitrogen
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HT-1080 | EC50 |
25.5 nM
Compound: 13
|
Anti-ferroptotic activity against RSL3-induced ferroptosis in human HT-1080 cells assessed as inhibition of ferroptosis incubated for 24 hrs by CCK-8 assay
Anti-ferroptotic activity against RSL3-induced ferroptosis in human HT-1080 cells assessed as inhibition of ferroptosis incubated for 24 hrs by CCK-8 assay
|
[PMID: 38056303] |
In Vitro
Ferroptosis-IN-6 (Compound 13) (24 h) hydrochloride is a potent inhibitor of RSL3 (HY-100218A)-induced ferroptosis in HT-1080 cells with an EC50 of 25.5 nM[1].
Ferroptosis-IN-6 (100 nM; 24 h) hydrochloride exhibits broad-spectrum protection against RSL3-induced ferroptosis in HT-1080, Huh-7, HeLa, HTR-8/Svneo, and HepG2 cell lines[1].
Ferroptosis-IN-6 (100 nM; 24 h) hydrochloride reduces RSL3-induced lipid ROS accumulation and inhibits the elevation of malondialdehyde (MDA) adduct levels in HT-1080 cells[1].
Ferroptosis-IN-6 hydrochloride has no significant effect on the protein and mRNA levels of key factors involved in iron metabolism and the antioxidant defense system in HT-1080 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6Nj (male, 8-12 weeks)[1]
-
Dosage:10 mg/kg
-
Administration:i.p.; twice (24 h before ischemia and 1 h prior); 24 h of reperfusion
-
Result:Reduced increased serum creatinine and blood urea nitrogen levels.
Mitigated I/R-induced pathological injuries including focal eosinophilic degeneration and necrosis of renal tubular epithelial cells.
Reduced formation of ischemia-reperfusion-induced 4-HNE in renal sections.
Chemical Information
-
CAS No. 1517780-59-4
-
Appearance Solid
-
Molecular Weight 227.30
-
Formula C15H17NO
-
Color Brown to dark brown
-
SMILES
OC1=C(C)C=CC=C1NCC2=CC=C(C)C=C2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
4°C, protect from light, stored under nitrogen
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)
Solvent & Solubility
In Vitro:
DMSO : 25 mg/mL (109.99 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
In Vivo:
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (11.00 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (11.00 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL. * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Protocols
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Ferroptosis Solutions
Ferroptosis is an iron-dependent, non-apoptotic form of regulated cell death characterized by lethal lipid peroxidation and sensitivity to suppression by iron chelators or lipophilic radical-trapping antioxidants. The core pathway links cystine uptake through system Xc−, glutathione availability, GPX4-dependent detoxification of phospholipid hydroperoxides, iron-dependent oxidative reactions, and polyunsaturated-phospholipid metabolism into a cell-death program that is biochemically and morphologically distinct from apoptosis, necrosis, and autophagy. The ferroptosis pathway is experimentally linked to phenotype through chemical and genetic perturbation. Erastin induces ferroptosis by inhibiting cystine uptake through system Xc− and weakening antioxidant defenses, while GPX4 inhibition or depletion causes lipid peroxide accumulation and ferroptotic cancer-cell death. ACSL4 and oxidizable arachidonoyl- or adrenoyl-containing phosphatidylethanolamines shape ferroptosis sensitivity by con
Purity & Documentation
-
Data Sheet (282 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 4.3995 mL | 21.9974 mL | 43.9947 mL | 109.9868 mL |
| 5 mM | 0.8799 mL | 4.3995 mL | 8.7989 mL | 21.9974 mL | |
| 10 mM | 0.4399 mL | 2.1997 mL | 4.3995 mL | 10.9987 mL | |
| 15 mM | 0.2933 mL | 1.4665 mL | 2.9330 mL | 7.3325 mL | |
| 20 mM | 0.2200 mL | 1.0999 mL | 2.1997 mL | 5.4993 mL | |
| 25 mM | 0.1760 mL | 0.8799 mL | 1.7598 mL | 4.3995 mL | |
| 30 mM | 0.1466 mL | 0.7332 mL | 1.4665 mL | 3.6662 mL | |
| 40 mM | 0.1100 mL | 0.5499 mL | 1.0999 mL | 2.7497 mL | |
| 50 mM | 0.0880 mL | 0.4399 mL | 0.8799 mL | 2.1997 mL | |
| 60 mM | 0.0733 mL | 0.3666 mL | 0.7332 mL | 1.8331 mL | |
| 80 mM | 0.0550 mL | 0.2750 mL | 0.5499 mL | 1.3748 mL | |
| 100 mM | 0.0440 mL | 0.2200 mL | 0.4399 mL | 1.0999 mL |
Ferroptosis-IN-6 Related Classifications
HY-163074 Related Classifications
Powered by Bioz